Timing of Severe Toxicity from Chemotherapy in Patients With Lung Cancer.

Background/aim: The aim of this study was to investigate the timing of severe toxicity in lung cancer patients receiving chemotherapy.

Patients And Methods: Patients with advanced non-small cell lung cancer or limited disease small cell lung cancer included in two randomized controlled trials were analysed. Severe toxicity was defined as grade 3-5 toxicity according to the Common Terminology Criteria for Adverse Events (CTCAE) v3.